ACRAD19 | Report Turnaround Time: PET | | Process | Details |
ACRAD25 | Report Turnaround Time: Mammography | | Outcome | Details |
ACRAD37 | Interpretation of CT Pulmonary Angiography (CTPA) for Pulmonary Embolism | | Outcome | Details |
PIMSH13 | Oncology: Mutation Testing for Stage IV Lung Cancer Completed Prior to the Start of Targeted Therapy | | Outcome | Details |
ACRAD36 | Incidental Coronary Artery Calcification Reported on Chest CT | | Outcome | Details |
ACRAD17 | Report Turnaround Time: MRI | | Process | Details |
ACRAD18 | Report Turnaround Time: CT | | Process | Details |
MSK1 | Patients Suffering From a Neck Injury who Improve Physical Function | | Outcome | Details |
MSK2 | Patients Suffering From an Upper Extremity Injury who Improve Physical Function | | Outcome | Details |
MSK3 | Patients Suffering From a Back Injury who Improve Physical Function | | Outcome | Details |
MSK4 | Patients Suffering From a Lower Extremity Injury who Improve Physical Function | | Outcome | Details |
MSK6 | Patients Suffering From a Neck Injury who Improve Pain | | Outcome | Details |
MSK7 | Patients Suffering From an Upper Extremity Injury who Improve Pain | | Outcome | Details |
MSK8 | Patients Suffering From a Back Injury who Improve Pain | | Outcome | Details |
MSK9 | Patients Suffering From a Lower Extremity Injury who Improve Pain | | Outcome | Details |
MSK5 | Patients Suffering From a Knee Injury who Improve Physical Function | | Outcome | Details |
MSK10 | Patients Suffering From a Knee Injury who Improve Pain | | Outcome | Details |
ACRAD16 | Report Turnaround Time: Ultrasound (Excluding Breast US) | | Process | Details |
ACRAD15 | Report Turnaround Time: Radiography | | Process | Details |
ACRAD41 | Use of Quantitative Criteria for Oncologic FDG PET Imaging | | Outcome | Details |
HM7 | Functional Status Change for Patients with Vestibular Dysfunction | | Outcome | Details |
PIMSH17 | Oncology: Utilization of Prophylactic GCSF for Cancer Patients Receiving Low-Risk Chemotherapy (inverse measure) | | Efficiency | Details |